Clifford Dacso

Title: The Innovative Contributions of Clifford Dacso

Introduction

Clifford Dacso is a notable inventor based in Houston, Texas, recognized for his significant contributions to cancer treatment through innovative methodologies. With a total of three patents to his name, Dacso's work focuses on the targeting of SRC-3 in immune cells, particularly T regulatory cells, to enhance therapeutic outcomes in cancer patients.

Latest Patents

Dacso's latest patent involves the targeting of SRC-3 in immune cells as an immunomodulatory therapeutic for the treatment of cancer. This patent outlines methods and compositions that leverage the targeting of SRC-3 in T regulatory cells, which has shown effectiveness in eradicating tumors in mammals. The patent also discusses the use of CRISPR technology to modify T regulatory cells ex vivo, creating cells suitable for adoptive cell transfer. Additionally, it mentions the administration of agents that target SRC-3 to enhance treatment efficacy.

Career Highlights

Clifford Dacso is affiliated with the Baylor College of Medicine, where he conducts research and develops innovative cancer therapies. His work is characterized by a commitment to advancing medical science and improving patient outcomes through targeted immunotherapy.

Collaborations

Dacso collaborates with esteemed colleagues, including Bert W O'Malley and Sang Jun Han, to further his research and explore new avenues in cancer treatment.

Conclusion

Clifford Dacso's innovative work in targeting SRC-3 in immune cells represents a significant advancement in cancer therapy. His contributions continue to pave the way for new treatment methodologies that hold promise for improving patient care.